24311-1-AP
antibody from Proteintech Group
Targeting: KDM2A
CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA
Antibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 24311-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- KDM2A antibody
- Antibody type
- Polyclonal
- Description
- KDM2A antibody (Cat. #24311-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references NLRP14 modulates the activity of E3 ubiquitin ligases during the oocyte-to-embryo transition.
Macrophage KDM2A promotes atherosclerosis via regulating FYN and inducing inflammatory response.
Targeting Intratumoral Copper Inhibits Tumor Progression via p62-Mediated EZH2 Degradation and Potentiates Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinoma.
SLC25A11 Is Associated with KDM2A-Dependent Reduction in rRNA Transcription Induced by Aminooxyacetic Acid.
Interaction Between PHF8 and a Segment of KDM2A, Which Is Controlled by the Phosphorylation Status at a Specific Serine in an Intrinsically Disordered Region of KDM2A, Regulates rRNA Transcription and Cell Proliferation in a Breast Cancer Cell Line.
Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome.
Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis.
CircRNF144B/miR-342-3p/FBXL11 axis reduced autophagy and promoted the progression of ovarian cancer by increasing the ubiquitination of Beclin-1.
Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma.
Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting ERα and Its Cofactor.
The ubiquitin ligase SCF(FBXW7α) promotes GATA3 degradation.
Liu S, Qi Q, Chi P, Jiao H, Yan L, Lu Y, Zhang R, Li J, Ju S, Han Z, Zhang Z, Liu Q, Ou G, Li J, Chen J, Wang X, Li L, Guo L, Jiao X, Hu H, Jiang Y, Deng D
Nature communications 2026 Apr 8;
Nature communications 2026 Apr 8;
Macrophage KDM2A promotes atherosclerosis via regulating FYN and inducing inflammatory response.
Xue Y, Peng Y, Jin L, Liu L, Liu Q, Yuan X, Wang J, Zhao M, Zhang W, Luo S, Li Y, Luo M, Huang L
International journal of biological sciences 2025;21(6):2780-2805
International journal of biological sciences 2025;21(6):2780-2805
Targeting Intratumoral Copper Inhibits Tumor Progression via p62-Mediated EZH2 Degradation and Potentiates Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinoma.
Lin X, Chen W, Li B, Zhao Z, Yu Z, Zhao XY, Zhou X, Feng Z, Lin C, Cao W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Oct;12(40):e17795
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Oct;12(40):e17795
SLC25A11 Is Associated with KDM2A-Dependent Reduction in rRNA Transcription Induced by Aminooxyacetic Acid.
Tanaka Y, Miyazawa N, Toba Y
Cells 2025 Oct 22;14(21)
Cells 2025 Oct 22;14(21)
Interaction Between PHF8 and a Segment of KDM2A, Which Is Controlled by the Phosphorylation Status at a Specific Serine in an Intrinsically Disordered Region of KDM2A, Regulates rRNA Transcription and Cell Proliferation in a Breast Cancer Cell Line.
Okamoto K, Mihara Y, Ogasawara S, Murakami T, Ohmori S, Mori T, Umata T, Kawasaki Y, Hirano K, Yano H, Tsuneoka M
Biomolecules 2025 May 2;15(5)
Biomolecules 2025 May 2;15(5)
Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome.
Cheng ST, Chen WX, Deng HJ, He X, Zhang H, Tan M, Yu HB, Zhang ZZ, Ren JH, Yang ML, Zhang DP, Li ZH, Chen J
Clinical and molecular hepatology 2025 Jul;31(3):841-865
Clinical and molecular hepatology 2025 Jul;31(3):841-865
Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis.
You HJ, Ma LH, Wang X, Wang YX, Zhang HY, Bao ES, Zhong YJ, Liu XY, Kong DL, Zheng KY, Kong FY, Tang RX
Cellular oncology (Dordrecht, Netherlands) 2024 Apr;47(2):639-655
Cellular oncology (Dordrecht, Netherlands) 2024 Apr;47(2):639-655
CircRNF144B/miR-342-3p/FBXL11 axis reduced autophagy and promoted the progression of ovarian cancer by increasing the ubiquitination of Beclin-1.
Song W, Zeng Z, Zhang Y, Li H, Cheng H, Wang J, Wu F
Cell death & disease 2022 Oct 8;13(10):857
Cell death & disease 2022 Oct 8;13(10):857
Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma.
Ai Y, Wu S, Zou C, Wei H
Journal of cellular and molecular medicine 2022 Mar;26(6):1842-1852
Journal of cellular and molecular medicine 2022 Mar;26(6):1842-1852
Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting ERα and Its Cofactor.
Yang M, Lee JH, Zhang Z, De La Rosa R, Bi M, Tan Y, Liao Y, Hong J, Du B, Wu Y, Scheirer J, Hong T, Li W, Fei T, Hsieh CL, Liu Z, Li W, Rosenfeld MG, Xu K
Cell reports 2020 Jun 23;31(12):107803
Cell reports 2020 Jun 23;31(12):107803
The ubiquitin ligase SCF(FBXW7α) promotes GATA3 degradation.
Song N, Cao C, Tang Y, Bi L, Jiang Y, Zhou Y, Song X, Liu L, Ge W
Journal of cellular physiology 2018 Mar;233(3):2366-2377
Journal of cellular physiology 2018 Mar;233(3):2366-2377
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The KDM2A antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human KDM2A. This antibody recognizes human, mouse antigen. The KDM2A antibody has been validated for the following applications: ELISA, WB analysis.